Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacovigilance01:19

Pharmacovigilance

1.8K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.8K
Labeling DNA Probes03:31

Labeling DNA Probes

9.5K
DNA probes are fragments of DNA labeled with a reporter tag to enable their detection or purification. The resulting labeled DNA probes can then hybridize to target nucleic acid sequences through complementary base-pairing, and may be used to recover or identify these regions.
Radioisotopes, fluorophores, or small molecule binding partners like biotin or digoxigenin, are the most widely used reporter tags for labeling DNA probes. These labels can be attached to the probe DNA molecule via...
9.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Global Perspective on the Evolution and Future of Pharmacovigilance: Deliverables from the 24th Annual Meeting of the International Society of Pharmacovigilance Celebrating 25 Years of Excellence.

Drug safety·2026
Same author

Reply to "A Comment about AI Methods that May Help Advance Pharmacovigilance".

Clinical pharmacology and therapeutics·2026
Same author

9<sup>th</sup> ISoP Intelligent Automation Boston Seminar: From Innovation to Impact. Building Trustworthy AI in Pharmacovigilance 4-5 December 2025 | Cambridge, USA & Virtual.

Drug safety·2026
Same author

Ontology-based Semantic Similarity Measures for Clustering Medical Concepts in Drug Safety.

AMIA ... Annual Symposium proceedings. AMIA Symposium·2026
Same author

Performance of the Self-Controlled Case Series for Drug Safety Signal Detection: A Multi-Database Study.

Pharmacoepidemiology and drug safety·2026
Same author

Through the lens of marketing authorization holders: experience in use of real-world data and real-world evidence in drug development and regulatory submissions in EU.

British journal of clinical pharmacology·2026
Same journal

Sensitivity Analyses of a Scoring System for a Contraception Decision Aid.

AMIA ... Annual Symposium proceedings. AMIA Symposium·2026
Same journal

Improving electronic health record processing of large language models via retrieval-augmented generation: A case study on dietary supplements.

AMIA ... Annual Symposium proceedings. AMIA Symposium·2026
Same journal

Developing a User-Centered Mobile Application Prototype: Bridging Lower-Limb Fracture Care from Skilled Nursing Facility and Back to the Community.

AMIA ... Annual Symposium proceedings. AMIA Symposium·2026
Same journal

KERAP: A Knowledge-Enhanced Reasoning Approach for Accurate Zero-shot Diagnosis Prediction Using Multi-agent LLMs.

AMIA ... Annual Symposium proceedings. AMIA Symposium·2026
Same journal

Automating Adjudication of Cardiovascular Events Using Large Language Models.

AMIA ... Annual Symposium proceedings. AMIA Symposium·2026
Same journal

Predictive Factors and State-Level Barriers to Postpartum Birth Control Usage in the United States: Insights from PRAMS Phase 8.

AMIA ... Annual Symposium proceedings. AMIA Symposium·2026
See all related articles

Related Experiment Video

Updated: Feb 24, 2026

TurboID-Based Proximity Labeling for In Planta Identification of Protein-Protein Interaction Networks
07:02

TurboID-Based Proximity Labeling for In Planta Identification of Protein-Protein Interaction Networks

Published on: May 17, 2020

26.2K

PVLens: Enhancing Pharmacovigilance Through Automated Label Extraction.

Jeffery L Painter1, Gregory E Powell1, Andrew Bate2,3

  • 1GSK, Durham, NC, USA.

AMIA ... Annual Symposium Proceedings. AMIA Symposium
|February 23, 2026
PubMed
Summary
This summary is machine-generated.

PVLens is a new automated system for drug safety data extraction from FDA labels, improving pharmacovigilance. It offers a more accurate and up-to-date alternative to static resources like SIDER.

More Related Videos

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.6K
Avidity-based Extracellular Interaction Screening AVEXIS for the Scalable Detection of Low-affinity Extracellular Receptor-Ligand Interactions
12:30

Avidity-based Extracellular Interaction Screening AVEXIS for the Scalable Detection of Low-affinity Extracellular Receptor-Ligand Interactions

Published on: March 5, 2012

22.2K

Related Experiment Videos

Last Updated: Feb 24, 2026

TurboID-Based Proximity Labeling for In Planta Identification of Protein-Protein Interaction Networks
07:02

TurboID-Based Proximity Labeling for In Planta Identification of Protein-Protein Interaction Networks

Published on: May 17, 2020

26.2K
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.6K
Avidity-based Extracellular Interaction Screening AVEXIS for the Scalable Detection of Low-affinity Extracellular Receptor-Ligand Interactions
12:30

Avidity-based Extracellular Interaction Screening AVEXIS for the Scalable Detection of Low-affinity Extracellular Receptor-Ligand Interactions

Published on: March 5, 2012

22.2K

Area of Science:

  • Pharmacovigilance and Drug Safety
  • Health Informatics
  • Regulatory Science

Background:

  • Existing drug safety databases like SIDER are outdated and static, hindering real-time pharmacovigilance.
  • Accurate and continuously updated safety information is crucial for monitoring drug risks.
  • There is a need for automated systems to efficiently extract and standardize safety data from regulatory documents.

Purpose of the Study:

  • To introduce PVLens, an automated system for extracting labeled drug safety information from FDA Structured Product Labels (SPLs).
  • To map extracted safety terms to the Medical Dictionary for Regulatory Activities (MedDRA) terminology.
  • To provide a scalable, accurate, and continuously updated resource for pharmacovigilance.

Main Methods:

  • Developed an automated system (PVLens) to extract safety information from FDA SPLs.
  • Integrated term mapping to MedDRA for standardized data representation.
  • Implemented a web-based review tool for expert oversight and validation.
  • Validated the system against 97 drug labels.

Main Results:

  • PVLens achieved a high F1 score of 0.882 in validation.
  • The system demonstrated high recall (0.983) and moderate precision (0.799).
  • PVLens successfully extracted and mapped safety information, outperforming static resources.

Conclusions:

  • PVLens offers a scalable and accurate solution for drug safety data extraction.
  • The system enhances real-time pharmacovigilance by providing contemporaneous insights.
  • PVLens represents a significant advancement over outdated, static drug safety databases.